RESUMO
Background: Co-infection rates increase in patients admitted to the Intensive Care Units. The aim of this study was to examine the Healthcare Associated Infections in critically ill adult patients infected with SARS-CoV-2. Methods: A retrospective observational study in adults with confirmed SARS-CoV-2 infection requiring intensive care unit admission was performed. From February 2020 to September 2021, healthcare records from a total of 118 patients were evaluated. Results: In the study period, 39 patients were diagnosed with at least 1 Healthcare Associated Infection (33.1%). The co-infection/co-colonisation rate >48 hours after admission was 29.0 per 1,000 person/days (95 % CI 19.1-33.9). A total of 94 isolates were identified, the most common being Klebsiella spp, Clostridium difficile, Acinetobacter baumanii and Enterococcus spp. Associated outcomes for Healthcare Associated Infections have been identified: age >64 years (p= .003), length of Intensive Care Unit stay> 7 days (p= .002), Type 2 Diabetes mellitus (p= .019), cardiovascular disease (p= .021), inserted central venous catheter (p= .014), intubation (p< .001), APACHE II score >25 (p< .001), mechanical ventilation 48 hours (p= .003), and inserted urinary catheter (p= .002). The overall fatality rate of patients included in the study was 41.5% (n= 49), and it was found to be significantly higher in patients who acquired a Healthcare Associated Infection (n=26/39, 66.7%) compared to those who did not acquire it (n= 23/79, 29.1%) (OR= 4.87; 95% CI = 2.14-11.10; p< .001). Conclusions: Our study showed high rates of Healthcare Associated Infections in critically ill adults with COVID-19. Associated factors for Healthcare Associated Infections acquisition and fatality in Intensive Care Units patients were identified as a good reason for a revision of existing infection control policies.
Assuntos
COVID-19 , Coinfecção , Infecção Hospitalar , Diabetes Mellitus Tipo 2 , Adulto , Humanos , Pessoa de Meia-Idade , COVID-19/epidemiologia , Estudos Retrospectivos , Estado Terminal , SARS-CoV-2 , Coinfecção/epidemiologia , Unidades de Terapia Intensiva , Infecção Hospitalar/epidemiologiaRESUMO
Oncology has come a long way in addressing patients' quality of life, together with developing surgical, radio-oncological and medical anticancer therapies. However, the multiple and varying needs of patients are still not being met adequately as part of routine cancer care. Supportive and palliative care interventions should be integrated, dynamic, personalised and based on best evidence. They should start at the time of diagnosis and continue through to end-of-life or survivorship. ESMO is committed to excellence in all aspects of oncological care during the continuum of the cancer experience. Following the 2003 ESMO stand on supportive and palliative care (Cherny N, Catane R, Kosmidis P. ESMO takes a stand on supportive and palliative care. Ann Oncol 2003; 14(9): 1335-1337), this position paper highlights the evolving and growing gap between the needs of cancer patients and the actual provision of care. The concept of patient-centred cancer care is presented along with key requisites and areas for further work.
Assuntos
Neoplasias/terapia , Cuidados Paliativos/métodos , Cuidados Paliativos/normas , Assistência Centrada no Paciente/métodos , Assistência Centrada no Paciente/normas , Humanos , Guias de Prática Clínica como Assunto , Qualidade de Vida , Assistência Terminal/métodos , Assistência Terminal/normasRESUMO
BACKGROUND: The activity of ginger in the management of chemotherapy-induced nausea and vomiting (CINV) has been suggested, but design inadequacies, heterogeneity of the population, small numbers and poor quality of tested products limit the possibility to offer generalizable results. PATIENTS AND METHODS: We conducted a randomized, double-blind, placebo-controlled, multicenter study in patients planned to receive ≥2 chemotherapy cycles with high dose (>50 mg/m2) cisplatin. Patients received ginger 160 mg/day (with standardized dose of bioactive compounds) or placebo in addition to the standard antiemetic prophylaxis for CINV, starting from the day after cisplatin administration. CINV was assessed through daily visual-analogue scale and Functional Living Index Emesis questionnaires. The main objective was protection from delayed nausea; secondary end points included intercycle nausea and nausea anticipatory symptoms. RESULTS: In total, 121 patients received ginger and 123 placebo. Lung (49%) and head and neck cancer (HNC; 35%) were the most represented tumors. No differences were reported in terms of safety profile or compliance. The incidence of delayed, intercycle and anticipatory nausea did not differ between the two arms in the first cycle and second cycle. A benefit of ginger over placebo in Functional Living Index Emesis nausea score differences (day 6-day 1) was identified for females (P = 0.048) and HNC patients (P = 0.038). CONCLUSIONS: In patients treated with high-dose cisplatin, the daily addition of ginger, even if safe, did not result in a protective effect on CINV. The favorable effect observed on nausea in subgroups at particular risk of nausea (females; HNC) deserves specific investigation.
Assuntos
Antieméticos/uso terapêutico , Cisplatino/efeitos adversos , Náusea/prevenção & controle , Neoplasias/tratamento farmacológico , Extratos Vegetais/uso terapêutico , Vômito/prevenção & controle , Zingiber officinale/química , Antineoplásicos/administração & dosagem , Antineoplásicos/efeitos adversos , Cisplatino/administração & dosagem , Relação Dose-Resposta a Droga , Método Duplo-Cego , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Náusea/induzido quimicamente , Extratos Vegetais/efeitos adversos , Vômito/induzido quimicamenteRESUMO
BACKGROUND: Data are lacking on the relationship between hope and other variables in non-advanced cancer patients. The study explored the relationship between hope, symptoms, needs, and spirituality/religiosity in patients treated in a supportive care unit (SCU). PATIENTS AND METHODS: From September 2013 to March 2014, the consecutive patients who accepted to complete: (i) Needs Evaluation Questionnaire (NEQ), (ii) the Edmonton Symptom Assessment System (ESAS), (iii) Hope Herth Index (HHI), and (iv) the System of Belief Inventory (SBI) were enrolled. Moreover, clinical/demographic data were collected and the findings were analyzed. RESULTS: A total of 276 patients who completed the HHI questionnaire (participation rate 276/300 = 92%) were included; 131 reported HHI total score >37 (median value). The majority of patients had a Karnofsky performance status >80; 71% were on cancer therapies, and only 29 patients had metastases or relapse. Patients with higher HHI scores were less educated (P = 0.012), reported lower ESAS total score (15.4 versus 22.6, P < 0.001), and had less often been referred to a psychologist previously to the study (P = 0.002); patients with a higher HHI score also reported higher spirituality (P < 0.001). Some NEQ items resulted significantly associated with HHI score after adjustment for other variables: the need to have sincere clinicians (ß = -2.7), better dialogue (ß = -2.1), and more reassurance from the clinicians (ß = -2.5); better attention (ß = -4.4) and respect for intimacy (ß = -3.3) from nurses; to speak with people who have the same illness experience (ß = -2.5), to be more reassured by relatives (ß = -3.3) and to feel less abandoned (ß = -4.3). Higher SBI scores were independently associated with higher HHI scores (ß = 1.7 for 10 points increase). CONCLUSIONS: In cancer patients, hope can be encouraged by clinicians through dialogue, sincerity, and reassurance, as well as assessing and considering the patients' needs (above all the psycho-emotional), symptoms, psychological frailty, and their spiritual/religious resources.
Assuntos
Esperança , Recidiva Local de Neoplasia/psicologia , Neoplasias/psicologia , Apoio Social , Espiritualidade , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/patologia , Neoplasias/patologia , Qualidade de Vida , Inquéritos e QuestionáriosRESUMO
In this study, we explored if urinary lithogenic risk parameters could have some application for monitoring bone health status. We recruited 20 women with postmenopausal osteopenia and a negative medical history for nephrolithiasis. Markers of lithogenic risk were evaluated on 24-h urine and fastingmorning urine. Serum levels of bone turnover markers (BTM) were measured in fasting-blood samples. We found that cross-linked telopeptide of type I collagen (CTX) was significantly correlated with 24-h calcium excretion. N-terminal propeptide of type I procollagen (PINP) correlated with 24-h excretion of potassium, calcium and citrate. CTX had considerably increased in patients with pH less than 5.5. Low citrate levels (less than 3.3 mmol/24 h) were associated with lower levels of CTX and PINP. Our findings suggest that a low-grade acidosis and some lithogenic risk factors are detectable in a proportion of patients with postmenopausal osteopenia. Further studies are necessary to confirm that this evaluation could be clinically relevant.
Assuntos
Biomarcadores/metabolismo , Colágeno Tipo I/metabolismo , Osteoporose Pós-Menopausa/metabolismo , Densidade Óssea , Remodelação Óssea , Feminino , Humanos , Fragmentos de Peptídeos/metabolismo , Peptídeos , Pós-Menopausa/metabolismo , Pró-Colágeno/metabolismo , Fatores de RiscoRESUMO
BACKGROUND: While guidelines are available for the management of cancer-related pain, little attention is given to the assessment and treatment of pain caused by treatments and diagnostic procedures in cancer patients. METHODS: We evaluated the literature on pain related to cancer treatment and diagnostic procedures within a critical analysis. RESULTS: The data available are sparse, suggesting that little attention has been directed at this important aspect of oncology. This points to potentially suboptimal patient management. CONCLUSIONS: Appropriate studies are necessary in order to understand the incidence and appropriate management of pain, both during and/or after oncological treatments and diagnostic procedures. At the same time, Health Care Professionals should have heightened awareness of the causes and treatment of pain with the aim of anticipating and managing pain most appropriately for each individual patient. This is clearly an important component of holistic patient care before, during, and after oncological treatment.
Assuntos
Neoplasias/diagnóstico , Neoplasias/terapia , Manejo da Dor/métodos , Dor/etiologia , Dor/prevenção & controle , Humanos , Neoplasias/complicaçõesRESUMO
BACKGROUND: Financial toxicity, defined as both the objective financial burden and subjective financial distress from a cancer diagnosis and its treatment, is a topic of interest in the assessment of the quality of life of patients with cancer and their families. Current evidence implicates financial toxicity in psychosocial, economic and other harms, leading to suboptimal cancer outcomes along the entire trajectory of diagnosis, treatment, supportive care, survivorship and palliation. This paper presents the results of a virtual consensus, based on the evidence base to date, on the screening and management of financial toxicity in patients with and beyond cancer organized by the European Society for Medical Oncology (ESMO) in 2022. METHODS: A Delphi panel of 19 experts from 11 countries was convened taking into account multidisciplinarity, diversity in health system contexts and research relevance. The international panel of experts was divided into four working groups (WGs) to address questions relating to distinct thematic areas: patients with cancer at risk of financial toxicity; management of financial toxicity during the initial phase of treatment at the hospital/ambulatory settings; financial toxicity during the continuing phase and at end of life; and financial risk protection for survivors of cancer, and in cancer recurrence. After comprehensively reviewing the literature, statements were developed by the WGs and then presented to the entire panel for further discussion and amendment, and voting. RESULTS AND DISCUSSION: A total of 25 evidence-informed consensus statements were developed, which answer 13 questions on financial toxicity. They cover evidence summaries, practice recommendations/guiding statements and policy recommendations relevant across health systems. These consensus statements aim to provide a more comprehensive understanding of financial toxicity and guide clinicians globally in mitigating its impact, emphasizing the importance of further research, best practices and guidelines.
Assuntos
Neoplasias , Humanos , Neoplasias/terapia , Neoplasias/economia , Consenso , Qualidade de Vida , Efeitos Psicossociais da Doença , Oncologia/economia , Oncologia/normas , Sociedades Médicas , Técnica DelphiAssuntos
Analgesia , Dor do Câncer , Administração Intravenosa , Adulto , Humanos , Morfina , Manejo da DorAssuntos
Dor do Câncer/terapia , Oncologia/normas , Neoplasias/complicações , Manejo da Dor/normas , Adulto , Analgésicos Opioides/normas , Analgésicos Opioides/uso terapêutico , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Dor Irruptiva/diagnóstico , Dor Irruptiva/epidemiologia , Dor Irruptiva/etiologia , Dor Irruptiva/terapia , Dor do Câncer/diagnóstico , Dor do Câncer/epidemiologia , Dor do Câncer/etiologia , Sobreviventes de Câncer , Europa (Continente) , Humanos , Oncologia/métodos , Estadiamento de Neoplasias , Neoplasias/diagnóstico , Neoplasias/patologia , Neoplasias/terapia , Manejo da Dor/métodos , Medição da Dor/métodos , Medição da Dor/normas , Dor Processual/diagnóstico , Dor Processual/epidemiologia , Dor Processual/etiologia , Dor Processual/terapia , Prevalência , Sociedades Médicas/normas , Assistência Terminal/métodos , Assistência Terminal/normas , Resultado do TratamentoAssuntos
Constipação Intestinal/terapia , Impacção Fecal/terapia , Oncologia/normas , Neoplasias/complicações , Adulto , Fatores Etários , Idoso , Envelhecimento/fisiologia , Analgésicos Opioides/efeitos adversos , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Dor do Câncer/tratamento farmacológico , Dor do Câncer/etiologia , Constipação Intestinal/diagnóstico , Constipação Intestinal/etiologia , Constipação Intestinal/psicologia , Enema/efeitos adversos , Enema/métodos , Enema/normas , Europa (Continente) , Impacção Fecal/diagnóstico , Impacção Fecal/etiologia , Impacção Fecal/psicologia , Motilidade Gastrointestinal/efeitos dos fármacos , Motilidade Gastrointestinal/fisiologia , Humanos , Laxantes/administração & dosagem , Laxantes/efeitos adversos , Massagem/métodos , Massagem/normas , Oncologia/métodos , Neoplasias/sangue , Neoplasias/terapia , Autocuidado/métodos , Autocuidado/normas , Sociedades Médicas/normas , Supositórios/administração & dosagem , Supositórios/efeitos adversos , Resultado do TratamentoAssuntos
Diarreia/terapia , Intolerância à Lactose/prevenção & controle , Oncologia/normas , Neoplasias/terapia , Cuidados Paliativos/normas , Adulto , Fatores Etários , Idoso , Analgésicos Opioides/efeitos adversos , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Biomarcadores/análise , Dor do Câncer/tratamento farmacológico , Dor do Câncer/etiologia , Diarreia/diagnóstico , Diarreia/etiologia , Diarreia/psicologia , Dietoterapia/métodos , Dietoterapia/normas , Europa (Continente) , Excipientes/efeitos adversos , Motilidade Gastrointestinal/efeitos dos fármacos , Motilidade Gastrointestinal/genética , Motilidade Gastrointestinal/imunologia , Motilidade Gastrointestinal/efeitos da radiação , Humanos , Lactose/efeitos adversos , Intolerância à Lactose/complicações , Intolerância à Lactose/diagnóstico , Intolerância à Lactose/etiologia , Anamnese , Oncologia/métodos , Estadiamento de Neoplasias , Neoplasias/sangue , Neoplasias/complicações , Cuidados Paliativos/métodos , Medicina de Precisão/métodos , Medicina de Precisão/normas , Autocuidado/métodos , Autocuidado/normas , Sociedades Médicas/normas , Procedimentos Cirúrgicos Operatórios/efeitos adversosAssuntos
Delírio/terapia , Oncologia/normas , Neoplasias/complicações , Adulto , Idoso , Analgésicos Opioides/efeitos adversos , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Antipsicóticos/uso terapêutico , Dor do Câncer/tratamento farmacológico , Dor do Câncer/etiologia , Terapia Cognitivo-Comportamental/métodos , Terapia Cognitivo-Comportamental/normas , Delírio/diagnóstico , Delírio/epidemiologia , Delírio/etiologia , Desprescrições , Substituição de Medicamentos/métodos , Substituição de Medicamentos/normas , Europa (Continente) , Família , Humanos , Incidência , Institucionalização/estatística & dados numéricos , Programas de Rastreamento/métodos , Programas de Rastreamento/normas , Oncologia/métodos , Estadiamento de Neoplasias , Neoplasias/terapia , Educação de Pacientes como Assunto/métodos , Educação de Pacientes como Assunto/normas , Polimedicação , Fatores de Risco , Sociedades Médicas/normas , Assistência Terminal/métodos , Assistência Terminal/normasRESUMO
The Patient-Generated Subjective Global Assessment (PG-SGA) is an instrument to screen, assess and monitor malnutrition and risk factors, and to triage for interventions. After having translated and culturally adapted the original PG-SGA for the Italian setting, according to International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Principles, we tested linguistic validity, i.e., perceived comprehensibility and difficulty, and content validity (relevance) of the Italian version of the PG-SGA in patients with cancer and a multidisciplinary sample of healthcare professionals (HCPs). METHODS: After the translation and cultural adaptation of the original PG-SGA for the Italian setting, the patient component (i.e., PG-SGA Short Form (SF) was tested for linguistic validity (i.e., comprehensibility ad difficulty) in 120 Italian patients with cancer and 81 Italian HCPs. The full PG-SGA, i.e., patient and professional component of the PG-SGA, was tested for content validity, i.e., relevance, in 81 Italian HCPs. The data were collected by a questionnaire and evaluations were operationalized by a 4-point scale. Through item and scale indices we evaluated the comprehensibility (I-CI, S-CI), difficulty (I-DI, S-DI) and content validity (I-CVI, S-CVI). Scale indices 0.80-0.89 were considered acceptable, and scale indices ≥0.90 were considered excellent. RESULTS: Patients perceived comprehensibility and difficulty of the PG-SGA SF (Boxes) as excellent (S-CI = 0.98, S-DI = 0.96). Professionals perceived comprehensibility of the professional component (Worksheets) as excellent (S-CI = 0.92), difficulty as acceptable (S-DI = 0.85), and content validity of the full PG-SGA as excellent (S-CVI = 0.92). Dietitians gave higher scores (indicating better scores) on comprehensibility, difficulty, and content validity of Worksheet 4 (physical exam) than the other professions. In Worksheet 4, four items were considered most difficult to complete and were considered below acceptable range. Relevance was perceived as excellent by professionals for both the patient component (S-CVI = 0.93) and the professional component (S-CVI = 0.90), resulting in S-CVI = 0.92 for the full PG-SGA. Slight textual modifications were implemented resulting in the final version of the Italian PG-SGA. CONCLUSIONS: Translation and cultural adaptation of the original PG-SGA resulted in the Italian version of the PG-SGA that maintained its original purpose and meaning and can be completed adequately and easily by patients and professionals. The Italian PG-SGA is considered relevant for screening, assessing and monitoring malnutrition and risk factors, as well as triaging for interventions by Italian HCPs.
Assuntos
Desnutrição , Neoplasias , Humanos , Estado Nutricional , Avaliação Nutricional , Desnutrição/diagnóstico , Neoplasias/diagnóstico , Neoplasias/complicações , LinguísticaRESUMO
Despite published guidelines and educational programs on the assessment and treatment of cancer-related pain, in any stage of oncological disease, unrelieved pain continues to be a substantial worldwide public health concern either in patients with solid and haematological malignancies. The proper and regular self-reporting assessment of pain is the first step for an effective and individualized treatment. Opioids are the mainstay of analgesic therapy and can be associated with non-opioids drugs such as paracetamol or non-steroidal anti-inflammatory drugs and to adjuvant drugs (for neuropathic pain and symptom control). The role and the utility of weak opioids (i.e. codeine, dihydrocodeine, tramadol) are a controversy point. Morphine has been placed by World Health Organization on its Essential Drug List. In the comparative study with other strong opioids (hydromorphone, oxycodone), there is no evidence to show superiority or inferiority with morphine as the first choice opioid. Oral methadone is a useful and safe alternative to morphine. Methadone presents the potential to control pain difficult to manage with other opioids. although the oral route of opioid administration is considered the one of choice, intravenous, subcutaneous, rectal, transdermal, sublingual, intranasal, and spinal routes must be used in particular situation. Transdermal opioids such as fentanyl and buprenorphine are best reserved for patients whose opioid requirements are stable. Switching from one opioid to another can improve analgesia and tolerability.
Assuntos
Analgésicos Opioides/administração & dosagem , Neoplasias , Manejo da Dor , Dor/tratamento farmacológico , Analgésicos Opioides/efeitos adversos , Relação Dose-Resposta a Droga , Fentanila/administração & dosagem , Humanos , Neoplasias/complicações , Neoplasias/tratamento farmacológico , Dor/complicações , Dor/epidemiologia , Medição da Dor , Resultado do TratamentoRESUMO
OBJECTIVE: The first instruments developed to evaluate specific logotherapeutic dimensions were the Purpose In Life (PIL) and the Seeking Of Noetic Goals (SONG) tests, designed to reflect Frankl's concepts of, respectively, meaning in life attainment and will to meaning. This study aims to perform the Italian cultural adaptation and the psychometric validation of the PIL and SONG questionnaires. METHODS: We administered the PIL and SONG, culturally adapted into the Italian language, to 266 cancer patients. The psychometric validation appraised construct validity, internal consistency, test-retest reliability, known-group validity, and convergent validity of the two questionnaires with respect to one another. RESULTS: The factorial analysis indicates that the original single-factor solution can be maintained for both instruments (proportion of variance explained by the first factor 77% and 71% for the PIL and SONG, respectively). The results show excellent internal consistency (Cronbach's alpha of 0.91 for the PIL and 0.90 for the SONG) and test-retest reliability (intraclass correlation coefficient of 0.92 for the PIL and 0.81 for the SONG). As expected, males, believers, patients nearer to the diagnosis, and patients not undergoing psychological therapy have higher PIL and lower SONG scores, while expectations for age were not confirmed. The average level for the PIL was 107.3, while for the SONG, it was 66.1, and a negative correlation (-0.47) between PIL and SONG scores indicates good convergent validity of the two instruments. CONCLUSION: Italian versions of the PIL and SONG are adequate and reliable self-report instruments for evaluating purpose in life and the motivation to find purpose for cancer patient populations.
Assuntos
Motivação , Neoplasias/psicologia , Psicoterapia/métodos , Inquéritos e Questionários , Adulto , Fatores Etários , Idoso , Estudos Transversais , Análise Fatorial , Feminino , Humanos , Itália , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Psicometria , Reprodutibilidade dos Testes , Fatores Sexuais , Fatores de TempoRESUMO
Macular degeneration is a leading cause of blindness. Treatments to rescue vision are currently limited. Here, we study how loss of central vision affects lateral feedback to spared areas of the human retina. We identify a cone-driven gain control mechanism that reduces visual function beyond the atrophic area in macular degeneration. This finding provides an insight into the negative effects of geographic atrophy on vision. Therefore, we develop a strategy to restore this feedback mechanism, through activation of laterally projecting cells. This results in improved vision in Cnga3-/- mice, which lack cone function, as well as a mouse model of geographic atrophy. Our work shows that a loss of lateral gain control contributes to the vision deficit in macular degeneration. Furthermore, in mouse models we show that lateral feedback can be harnessed to improve vision following retinal degeneration.
Assuntos
Atrofia Geográfica , Degeneração Macular , Degeneração Retiniana , Animais , Atrofia Geográfica/genética , Atrofia Geográfica/terapia , Degeneração Macular/genética , Camundongos , Células Fotorreceptoras Retinianas Cones/fisiologia , Degeneração Retiniana/complicações , Degeneração Retiniana/genética , Degeneração Retiniana/terapia , Visão OcularRESUMO
Polytherapy, namely the simultaneous application of three fundamental elements necessary for bone regeneration (growth factors, osteogenic cells and osteoconductive scaffolds) seems to lead to a very high success rate in the treatment of complex non-union (NU) cases and critical bone defects. NU are reported in 5-10% of long bone fractures. The use of autologous bone grafts has been long-considered the gold standard for the treatment of these cases. However the harvesting procedure from the iliac crest increases surgery time and presents some donor site complications which may be elevated. In recent years, surgeons have some alternatives to autologous grafting such as: application of organic or synthetic bone substitute, application of mesenchymal stromal cells (MSC) or growth factors (GF). In the literature there are many studies available about their application in monotherapy, but unfortunately the healing rate doesn't exceed 90%. Polytherapy seems to be a logical option to improve the healing rate, nevertheless, there are not still extensive studies that validate this strategy and moreover, some questions are not resolved.
Assuntos
Regeneração Óssea/fisiologia , Peptídeos e Proteínas de Sinalização Intercelular/uso terapêutico , Osteócitos/transplante , Alicerces Teciduais , Animais , Biomarcadores , Doenças Ósseas/terapia , Regeneração Óssea/efeitos dos fármacos , Substitutos Ósseos , Transplante Ósseo , Terapia Combinada , Fixação de Fratura , Fraturas Ósseas/terapia , Humanos , Estudos Multicêntricos como Assunto , Regulação para Cima/fisiologiaRESUMO
BACKGROUND: No study has so far addressed whether differences do exist in the management of cancer-related pain in patients admitted to oncology and non-oncology settings. PATIENTS AND METHODS: A multicentre cross-sectional study in 48 Italian hospitals has enrolled 819 patients receiving analgesic therapy for cancer-related pain. Demographics and clinical and analgesic therapy information have been prospectively collected by standardized forms. Adequacy of pain management has been evaluated by the Pain Management Index (PMI). RESULTS: Differences in the analgesic drug administration according to settings of care have been evident, non-opioids more frequently being administered in non-oncology units (19.6% versus 7.0%; P < 0.0001), while strong opioids are more frequently used in the oncology units (69.5% versus 51.9%; P < 0.0001). The number of patients receiving inadequate therapy (PMI < 0) has lowered in oncology compared with non-oncology units (11.3% versus 18.8%; P = 0.0024). Results of multiple logistic regression analysis have shown that the admission to non-oncology setting [odds ratio (OR) = 1.75, 95% confidence interval (CI) = 1.15-2.67; P = 0.0096] and the absence of metastatic disease (OR = 1.60, 95% CI = 1.04-2.44; P = 0.0317) were independent factors associated with an increased risk of receiving an inadequate analgesic therapy. CONCLUSION: Oncology wards provide the most adequate standard of analgesic therapy for cancer-related pain.